Ashford Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$24.7M |
| 2 |
Harmony Biosciences
HRMY
|
+$11M |
| 3 |
YMAB
Y-mAbs Therapeutics
YMAB
|
+$10.1M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
+$8.7M |
| 5 |
Incyte
INCY
|
+$8.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
+$30.9M |
| 2 |
Appian
APPN
|
+$25M |
| 3 |
Fiverr
FVRR
|
+$24.7M |
| 4 |
GLUU
Glu Mobile Inc.
GLUU
|
+$13.7M |
| 5 |
Trade Desk
TTD
|
+$12.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.43% |
| 2 | Industrials | 18.1% |
| 3 | Healthcare | 17.44% |
| 4 | Communication Services | 11.86% |
| 5 | Financials | 9.83% |
Similar funds
Ashford Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Ashford Capital Management held 117 positions worth $1.03B, up 23% from $841M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ashford Capital Management withdrew a net $33M in Q4 2020, closing 8 positions and reducing 38 holdings. Its most notable exit was Livongo Health, Inc. Common Stock, an estimated $30.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Ashford Capital Management opened a new position in Teladoc Health worth $24.3M.
- Ashford Capital Management's largest Q4 2020 buy was Teladoc Health: 121,567 shares worth $24.3M.
- Ashford Capital Management added most to Supernus Pharmaceuticals in Q4 2020, an estimated $8.7M increase.
- Ashford Capital Management's biggest Q4 2020 reduction was Appian, cutting an estimated $25M.
- Ashford Capital Management fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $30.9M.
- Ashford Capital Management's ten largest holdings make up 36% of its $1.03B portfolio in Q4 2020.
- Ashford Capital Management opened 20 new positions and closed 8 in Q4 2020.
- Ashford Capital Management's portfolio value rose 23% quarter-over-quarter to $1.03B.
Based on Ashford Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.